mechanistic
Analysis v1
Strong Support
A drug called dapagliflozin helps reduce scarring in heart cells, but when scientists turn on a specific cellular pathway with another chemical, that helpful effect disappears.
6
0
Evidence from Studies
Supporting (1)
6
Community contributions welcome
6
Dapagliflozin attenuates post-infarction fibrosis via cardiomyocyte protection and fibroblast inhibition.
Cohort Study
Animal
2025 Dec 15The study found that dapagliflozin helps reduce heart scarring, but when scientists turned on a specific cell signal (Wnt/β-catenin) with a drug called CHIR99021, dapagliflozin stopped working — which is exactly what the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.